Monalizumab

6 trials 2 recruiting

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

2 Recruiting

4 Completed trials

4 Sponsors

9 Countries

Phase III

Phase II

Phase III: 2 Phase II: 4

Indications tested

Head and neck cancer 1 Non-small cell lung cancer stage III 1 Non-small cell lung cancer stage II 1 Non-small cell lung cancer 1 Non-small cell lung cancer stage IIIB 1 Microsatellite instability cancer 1 Non-small cell lung cancer stage IIIA 1

Sponsors using this IMP

AstraZeneca AB 3 Assistance Publique Hopitaux De Paris 1 Centre Hospitalier Regional De Marseille 1 Humanitas Mirasole S.p.A. 1

All trials

6 total

Monalizumab infusion in patients with acute myeloid leukemia or myelodysplastic syndrome undergoing haploidentical hematopoietic stem cell t… Recruiting

2024-516974-31-00 Phase II 1 country Humanitas Mirasole S.p.A.
Study of Neoadjuvant and Adjuvant Treatment in Patients with Resectable Non-small Cell Lung Cancer Recruiting

2023-508852-21-00 Phase II 7 countries AstraZeneca AB
A Global Study to Assess the Effects of Durvalumab with Oleclumab or Durvalumab with Monalizumab Following Concurrent Chemoradiation in Pati… Ended

2023-503999-24-00 Phase III 6 countries AstraZeneca AB
Study of Monalizumab Given With Cetuximab or Placebo Given with Cetuximab in Patients With Head and Neck Cancer that has come back or spread… Ended

2024-511813-39-00 Phase III 1 country AstraZeneca AB
Precision Immuno-Oncology for advanced Non-small cell lung cancer patients with PD-1 ICI Resistance (PIONeeR clinical study) Ended

2024-515532-72-00 Phase II 1 country Centre Hospitalier Regional De Marseille
Monalizumab and MEDI5752 in patients with MSI and/or dMMR metastatic cancer (MONAMI) Ended

2024-511857-23-00 Phase II 1 country Assistance Publique Hopitaux De Paris

Showing 1–6 of 6 trials

← All drugs A–Z